ArticleMolecules (Basel, Switzerland)2021
Volatiles and Antifungal-Antibacterial-Antiviral Activity of South African
Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 21 citations in OpenAlex.
- An Ethnopharmacological Survey on Medicinally Important Plants of Genus Salvia.Combinatorial chemistry & high throughput screening · 2025Review
- Aerobiology of the Family Lamiaceae: Novel Perspectives with Special Reference to Volatiles Emission.Plants (Basel, Switzerland) · 2024Review
- Natural Compounds ofBiomedicines · 2023Review
- Advances in the Phytochemical Characterisation and Bioactivities ofPlants (Basel, Switzerland) · 2023Article
- Essential Oils and Biological Activities ofPlants (Basel, Switzerland) · 2023Article
- Unveiling the Chemical Composition and Biological Properties ofPlants (Basel, Switzerland) · 2023Article
- In vitro antifungal activity of heterocyclic organoboron compounds against Trichophyton mentagrophytes and Microsporum canis obtained from clinical isolates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022Article
- Uncommon Terpenoids fromMolecules (Basel, Switzerland) · 2022Review
- Therapeutic benefits ofHeliyon · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spontaneous emissions of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.